BD and ChemoGLO™ Join Forces to Enhance Hazardous Drug Testing in Healthcare

In a significant stride towards elevating safety standards in healthcare, BD (Becton, Dickinson and Company) and ChemoGLO™ have announced a strategic collaboration aimed at improving hazardous drug contamination testing in healthcare facilities. This partnership is designed to provide enhanced protection for healthcare workers against exposure to hazardous drugs, ensuring a safer working environment.

The Collaboration Explained

BD, renowned for its innovative medical technologies, is teaming up with ChemoGLO™, specialists in hazardous drug detection and decontamination, to offer a combined approach to contamination testing. The collaboration promises to integrate the rapid, point-of-care testing capabilities of the BD® HD Check System with ChemoGLO™'s precise liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis. This synergistic method will allow for swift identification of hazardous drug exposure, supported by comprehensive quantitative data.

Using the BD® HD Check System, healthcare facilities can obtain qualitative results in just ten minutes. Samples collected can then be sent to ChemoGLO™ for in-depth analysis, with quantitative reports available within three to five days. This efficient process not only expedites testing but also supports healthcare institutions in developing better strategies to protect their staff from contamination risks.

A Commitment to Safety

Eric Borin, Worldwide President of BD Medication Delivery Solutions, emphasized the dual benefits of this collaboration: "With the BD® HD Check System, facilities can quickly identify potential contamination, and through our collaboration with ChemoGLO™, gain deeper insights into exposure risks. This dual approach helps pinpoint areas of improvement and reinforces our commitment to healthcare worker safety."

Cara Zamboni, CEO of ChemoGLO™, articulated the shared mission of both entities: "By partnering with BD, we're combining speed and precision to help facilities act faster and more confidently to safeguard their teams." The urgency of this joint venture aligns with recommendations from a 2020 consensus conference that emphasized the importance of dual testing methods in ensuring environmental safety.

Streamlined Testing Workflow

Together, BD and ChemoGLO™ provide a streamlined sampling and testing workflow that empowers healthcare facilities to monitor contamination effectively. This approach not only aids in real-time risk assessment but also aligns with safety directives focused on reducing exposure risks for healthcare professionals.

As hospitals and healthcare systems increasingly prioritize the health and safety of their staff, this new testing partnership represents a vital step towards proactive contamination management—vital in protecting healthcare personnel who work with hazardous drugs daily.

Upcoming Presentation at ASHP

Those interested in learning more about this innovative collaboration can visit BD at Booth 1017 and ChemoGLO™ at Booth 1873 during the upcoming American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting in Las Vegas from December 6-10, 2025. This event will offer deeper insights into how the collaboration is shaping the future of health safety for workers within healthcare environments.

About BD

BD is one of the world’s largest medical technology companies. Committed to enhancing the world of health, BD's innovations span various areas of healthcare—from diagnostics to clinical processes. With a robust global presence, BD partners with stakeholders to address critical health issues, boost care efficiency, and ensure safe outcomes for patients and healthcare professionals alike. To learn more about BD, visit bd.com.

About ChemoGLO™

ChemoGLO™ has been a pioneer in healthcare safety for over 20 years, specializing in the detection and management of hazardous drug contamination. The company's innovative testing solutions enable accurate assessment of hazardous drug levels in multiple settings. With a commitment to safety, ChemoGLO™ continues to provide unparalleled services to safeguard patients and healthcare teams. For more information, visit chemoglo.com.